Editas Medicine Ownership | Who Owns Editas Medicine?

Overview Forecast RevenueFinancials Chart

Editas Medicine Ownership Summary

Editas Medicine is owned by 48.86% institutional investors, 0.31% insiders, and 50.83% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.50% of EDIT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.12% of its assets in Editas Medicine shares.

EDIT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Editas Medicine	48.86%	0.31%	50.83%
Sector	Healthcare Stocks	492.67%	11.09%	-403.76%
Industry	Biotech Stocks	295.31%	11.22%	-206.53%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	8.02M	9.50%	$27.83M
Blackrock	7.78M	9.50%	$36.34M
Vanguard group	6.97M	8.25%	$24.17M
Millennium management	2.75M	3.33%	$3.49M
Nuveen	2.09M	2.48%	$7.26M
Geode capital management	2.04M	2.42%	$7.08M
State street	1.87M	2.27%	$2.38M
Goldman sachs group	1.79M	2.17%	$2.27M
Two sigma advisers, lp	1.66M	2.01%	$2.10M
Two sigma investments, lp	1.65M	2.00%	$2.09M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Green alpha advisors	146.41K	0.49%	$508.05K
Dynamic technology lab private	72.84K	0.04%	$253.00M
Dlk investment management	29.32K	0.04%	$101.74K
R squared	20.63K	0.03%	$71.57K
Hennion & walsh asset management	241.69K	0.03%	$838.67K
Kennedy capital management	567.62K	0.03%	$1.25M
Headlands	76.58K	0.02%	$265.71K
Thrive wealth management	33.50K	0.02%	$116.25K
Xtx topco	132.94K	0.01%	$292.46K
Aries wealth management	12.50K	0.01%	$43.38K

Top Buyers

Holder	Shares	% Assets	Change
Renaissance	1.45M	0.00%	1.45M
Blackrock funding, inc. /de	8.02M	0.00%	1.20M
Nuveen	2.09M	0.00%	1.14M
Ubs group	1.12M	0.00%	704.47K
Aqr capital management	1.07M	0.00%	693.96K

Top Sellers

Holder	Shares	% Assets	Change
Deep track capital, lp	-	-	-4.90M
Ubs asset management americas	-	-	-2.60M
Avidity partners management lp	-	-	-1.47M
Balyasny asset management	-	-	-1.30M
Pictet asset management sa	-	-	-1.16M

New Positions

Holder	Shares	% Assets	Change	Value
Bridgeway capital management	150.00K	0.00%	150.00K	$190.50K
Dynamic technology lab private	72.84K	0.04%	72.84K	$253.00M
Graham capital management	40.63K	0.00%	40.63K	$89.39K
Baader bank aktiengesellschaft	14.54K	0.00%	14.54K	$31.20K
Hoylecohen	11.83K	0.00%	11.83K	$55.27K

Sold Out

Holder	Change
Gps wealth strategies group	-2.00
Pacific capital wealth advisors	-5.00
Sittner & nelson	-6.00
Baldwin brothers llc/ma	-8.00
Innealta capital	-15.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	191	-3.54%	41,244,466	-6.30%	48	1.74%	72	-	52	-8.77%
Mar 31, 2025	196	-6.67%	44,003,328	-13.78%	52	1.38%	69	-27.37%	59	-1.67%
Dec 31, 2024	94	-60.17%	19,933,396	-63.85%	24	0.54%	38	-62.00%	22	-65.63%
Sep 30, 2024	234	-2.50%	55,137,509	-2.17%	66	1.43%	100	-10.71%	64	-12.33%
Jun 30, 2024	238	2.15%	56,360,093	-17.01%	68	0.86%	111	-	71	16.39%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	2.59M	3.12%	-
Vanguard Total Stock Mkt Idx Inv	2.54M	2.90%	-55.93K
iShares Russell 2000 ETF	2.07M	2.30%	-
Vanguard Strategic Equity Inv	1.87M	2.24%	-
Nuveen Quant Small Cap Equity R6	1.63M	1.81%	898.10K
Pictet Biopharmaceutical Mother	1.15M	1.38%	42.67K
Vanguard Small Cap Index	1.04M	1.26%	2.50K
Selectra J. Lamarck Biotech A	1.10M	1.23%	-
Fidelity Small Cap Index	848.54K	0.97%	2.54K
UBS (Lux) Digital Health Equity SB USD	800.00K	0.96%	-370.00K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 03, 2025	Burkly Linda	EVP, CHIEF SCIENTIFIC OFFICER	Sell	$1.84K
Sep 03, 2025	Parison Amy	SVP, Chief Financial Officer	Sell	$1.19K
Sep 03, 2025	O'Neill Gilmore Neil	CEO	Sell	$14.52K
Aug 07, 2025	Parison Amy	SVP, Chief Financial Officer	Sell	$1.75K
Jul 31, 2025	Burkly Linda	EVP, CHIEF SCIENTIFIC OFFICER	Sell	$12.76K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	5
2025 Q2	-	3
2025 Q1	-	3
2024 Q4	-	2
2024 Q3	-	4

EDIT Ownership FAQ

Who Owns Editas Medicine?

Editas Medicine shareholders are primarily institutional investors at 48.86%, followed by 0.31% insiders and 50.83% retail investors. The average institutional ownership in Editas Medicine's industry, Biotech Stocks , is 295.31%, which Editas Medicine falls below.

Who owns the most shares of Editas Medicine?

Editas Medicine’s largest shareholders are Blackrock funding, inc. /de (8.02M shares, 9.50%), Blackrock (7.78M shares, 9.50%), and Vanguard group (6.97M shares, 8.25%). Together, they hold 27.25% of Editas Medicine’s total shares outstanding.

Does Blackrock own Editas Medicine?

Yes, BlackRock owns 9.50% of Editas Medicine, totaling 7.78M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 36.34M$. In the last quarter, BlackRock decreased its holdings by -50.264K shares, a -0.64% change.

Who is Editas Medicine’s biggest shareholder by percentage of total assets invested?

Green alpha advisors is Editas Medicine’s biggest shareholder by percentage of total assets invested, with 0.49% of its assets in 146.41K Editas Medicine shares, valued at 508.05K$.

Who is the top mutual fund holder of Editas Medicine shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Editas Medicine shares, with 3.12% of its total shares outstanding invested in 2.59M Editas Medicine shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools